Natural killer cell cytotoxicity and lymphocyte perforin expression in veterans with posttraumatic stress disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 4, 2010, Pages 597-604

  Gotovac, Katja ^a   Vidović, Andelko ^a   Vukušić, Herman ^b   Krčmar, Tomislav ^a   Sabioncello, Ante ^a   Rabatić, Sabina ^a   Dekaris, Dragan ^c  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

^b KBC Zagreb   (Croatia)

^c CROATIAN ACADEMY OF SCIENCES AND ARTS   (Croatia)

Author keywords

Glucocorticoid receptors; HPA axis; Intracellular perforin; NK cell activity; PTSD; War trauma

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GLUCOCORTICOID RECEPTOR; PERFORIN;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROATIA; CYTOTOXIC T LYMPHOCYTE; DEPRESSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFE STRESS; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PENSION; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; VETERAN;

COMBAT DISORDERS; CROATIA; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LIFE CHANGE EVENTS; LYMPHOCYTES; MALE; PERFORIN; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; VETERANS;

EID: 77952674749     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.02.018     Document Type: Article

References (89)

1. Abdeljaber M.H., Nair M.P., Schork M.A., Schwartz S.A. Depressed natural killer cell activity in schizophrenic patients. Immunol Invest 1994, 23:259-268.
2. Ader R., Cohen N., Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 1995, 345:99-103.
3. Altemus M., Dhabhar F.S., Yang R. Immune function in PTSD. Ann N Y Acad Sci 2006, 1071:167-183.
4. Diagnostic and statistical manual of mental disorders DSM-IV-TR 2000, American Psychiatric Association, American Psychiatric Publishing Inc., Washington, DC. 4th ed.
5. Baker D.G., Ekhator N.N., Kasckow J.W., Hill K.K., Zoumakis E., Dashevsky B.A., et al. Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation 2001, 9:209-217.
6. Bartlett J.A., Goldklang A.R., Schleifer S.J., Keller S.E. Immune function in healthy inner-city children. Clin Diagn Lab Immunol 2001, 8:740-746.
7. Benschop R.J., Brosschot J.F., Godaert G.L., De Smet M.B., Geenen R., Olff M., Heijnen C.J., Ballieux R.E. Chronic stress affects immunologic but not cardiovascular responsiveness to acute psychological stress in humans. Am J Physiol 1994, 266:R75-R80.
8. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory Manual 1996, The Psychological Corporation, San Antonio. 2nd ed.
9. Berki T., Kumanovics G., Kumanovics A., Falus A., Ujhelyi E., Nemeth P. Production and flow cytometric application of a monoclonal anti-glucocorticoid receptor antibody. J Immunol Methods 1998, 214:19-27.
10. Benyamini Y., Solomon Z. Combat stress reactions, posttraumatic stress disorder, cumulative life stress, and physical health among Israeli veterans twenty years after exposure to combat. Soc Sci Med 2005, 61:1267-1277.
11. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995, 8:75-90.
12. Borella P., Bargellini A., Rovesti S., Pinelli M., Vivoli R., Solfrini V., Vivoli G. Emotional stability, anxiety, and natural killer activity under examination stress. Psychoneuroendocrinology 1999, 24:613-627.
13. Boscarino J.A. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann N Y Acad Sci 2004, 1032:141-153.
14. Boscarino J.A., Chang J. Higher abnormal leukocyte and lymphocyte counts 20years after exposure to severe stress: research and clinical implications. Psychosom Med 1999, 61:378-386.
15. Brosschot J.F., Benschop R.J., Godaert G.L., Olff M., De Smet M., Heijnen C.J., Ballieux R.E. Influence of life stress on immunological reactivity to mild psychological stress. Psychosom Med 1994, 56:216-224.
16. Chahal H.S., Drake W.M. The endocrine system and ageing. J Pathol 2007, 211:173-180.
17. Delahanty D.L., Dougall A.L., Craig K.J., Jenkins F.J., Baum A. Chronic stress and natural killer cell activity after exposure to traumatic death. Psychosom Med 1997, 59:467-476.
18. de Kloet C.S., Vermetten E., Geuze E., Kavelaars A., Heijnen C.J., Westenberg H.G.M. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res 2006, 40:550-567.
19. de Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., et al. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol Psychiatry 2007, 12:443-453.
20. de Kloet C., Vermetten E., Lentjes E., Geuze E., van Pelt J., Manuel R., et al. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder. Psychoneuroendocrinology 2008, 33:313-320.
21. Dokur M., Boyadjieva N., Sarkar D.K. Catecholaminergic control of NK cell cytolytic activity regulatory factors in the spleen. J Neuroimmunol 2004, 151:148-157.
22. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000, 52:595-638.
23. Freeman T., Powell M., Kimbrell T. Measuring symptom exaggeration in veterans with chronic posttraumatic stress disorder. Psychiatry Res 2008, 158:374-380.
24. Frueh B.C., Hamner M.B., Cahill S.P., Gold P.B., Hamlin K.L. Apparent symptom overreporting in combat veterans evaluated for PTSD. Clin Psychol Rev 2000, 20:853-885.
25. Gill J., Vythilingam M., Page G.G. Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD. J Trauma Stress 2008, 21:530-539.
26. Gill J.M., Saligan L., Woods S., Page G. PTSD is associated with an excess of inflammatory immune activities. Perspect Psychiatr Care 2009, 45:262-277.
27. Glover D.A., Steele A.C., Stuber M.L., Fahey J.L. Preliminary evidence for lymphocyte distribution differences at rest and after acute psychological stress in PTSD-symptomatic women. Brain Behav Immun 2005, 19:243-251.
28. Gold P.B., Frueh B.C. Compensation-seeking and extreme exaggeration of psychopathology among combat veterans evaluated for posttraumatic stress disorder. J Nerv Ment Dis 1999, 187:680-684.
29. Gotovac K., Sabioncello A., Rabatić S., Berki T., Dekaris D. Flow cytometric determination of glucocorticoid receptor (GCR) expression in lymphocyte subpopulations: lower quantity of GCR in patients with post-traumatic stress disorder (PTSD). Clin Exp Immunol 2003, 131:335-339.
30. Gregurek R., Pavić L., Vuger-Kovačić H., Potrebica S., Bitar Z., Kovačić D., Danić S. Increase of frequency of post-traumatic stress disorder in disabled war veterans during prolonged stay in a rehabilitation hospital. Croat Med J 2001, 42:161-164.
31. Gruver A.L., Hudson L.L., Sempowski G.D. Immunosenescence of ageing. J Pathol 2007, 211:144-156.
32. Gulan G., Ravlić-Gulan J., Štrbo N., Sotošek V., Nemec B., Matovinović D., Rubinić D., Podack E.R., Rukavina D. Systemic and local expression of perforin in lymphocyte subsets in acute and chronic rheumatoid arthritis. J Rheumatol 2003, 30:660-670.
33. Hoge E.A., Brandstetter K., Moshier S., Pollack M.H., Wong K.K., Simon N.M. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009, 26:447-455.
34. Ironson G., Wynings C., Schneiderman N., Baum A., Rodriguez M., Greenwood D., Benight C., Antoni M., LaPerriere A., Huang H.S., Klimas N., Fletcher M.A. Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosom Med 1997, 59:128-141.
35. Ironson G., Cruess D., Kumar M. Immune and neuroendocrine alterations in post-traumatic stress disorder. Psychoneuroimmunology 2007, 531-547. Elsevier Academic Press, Oxford, UK. 2nd ed. R. Ader (Ed.).
36. Jung W., Irwin M. Reduction of natural killer cytotoxic activity in major depression: interaction between depression and cigarette smoking. Psychosom Med 1999, 61:263-270.
37. Kappel M., Tvede N., Galbo H., Haahr P.M., Kjaer M., Linstow M., et al. Evidence that the effect of physical exercise on NK cell activity is mediated by epinephrine. J Appl Physiol (Bethesda, Md: 1985) 1991, 70:2530-2534.
38. Karlović D., Martinac M., Buljan D., Zoričić Z. Relationship between serum lipid concentrations and posttraumatic stress disorder symptoms in soldiers with combat experiences. Acta Med Okayama 2004, 58:23-27.
39. Kaštelan M., Prpić Massari I., Gruber F., Zamolo G., Zauhar G., et al. Perforin expression is upregulated in the epidermis of psoriatic lesions. Br J Dermatol 2004, 151:831-836.
40. Kawamura N., Kim Y., Asukai N. Suppression of cellular immunity in men with a past history of posttraumatic stress disorder. Am J Psychiatry 2001, 158:484-486.
41. Keane T.M., Caddell J.M., Taylor K.L. Mississippi Scale for combat-related posttraumatic stress disorder: three studies in reliability and validity. J Consult Clin Psychol 1988, 56:85-90.
42. Keane T.M., Newman E., Orsillo S.M. The assessment of military-related PTSD. Assessing psychological trauma and PTSD 1996, 267-290. The Guilford Press, New York. 1st ed. J.P. Wilson, T.M. Keane (Eds.).
43. Kozarić-Kovačić D., Borovečki A. Prevalence of psychotic comorbidity in combat-related post-traumatic stress disorder. Mil Med 2005, 170:223-226.
44. Kozarić-Kovačić D., Bajs M., Vidosić S., Mati A., Alegić Karin A., Peraica T. Change of diagnosis of post-traumatic stress disorder related to compensation-seeking. Croat Med J 2004, 45:427-433.
45. Laudenslager M.L., Aasal R., Adler L., Berger C.L., Montgomery P.T., Sandberg E., Wahlberg L.J., Wilkins R.T., Zweig L., Reite M.L. Elevated cytotoxicity in combat veterans with long-term post-traumatic stress disorder: preliminary observations. Brain Behav Immun 1998, 12:74-79.
46. Lemieux A., Coe C.L., Carnes M. Symptom severity predicts degree of T cell activation in adult women following childhood maltreatment. Brain Behav Immun 2008, 22:994-1003.
47. Li Q., Liang Z., Nakadai A., Kawada T. Effect of electric foot shock and psychological stress on activities of murine splenic natural killer and lymphokine-activated killer cells, cytotoxic T lymphocytes, natural killer receptors and mRNA transcripts for granzymes and perforin. Stress 2005, 8:107-116.
48. Lindley S.E., Carlson E.B., Benoit M. Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol Psychiatry 2004, 55:940-945.
49. Lyons J.A., Caddell J.M., Pittman R.L., Rawls R., Perrin S. The potential for faking on the Mississippi Scale for Combat-related PTSD. J Trauma Stress 1994, 7:441-445.
50. Maes M., Lin A.H., Delmeire L., Van Gastel A., Kenis G., De Jongh R., Bosmans E. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999, 45:833-839.
51. Maher K.J., Klimas N.G., Fletcher M.A. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol 2005, 142:505-511.
52. Swa M., Janes G.R., Goldberg J., Eisen S.A., True W.R., Henderson W.G. A twin study of the association of post-traumatic stress disorder and combat exposure with long-term socioeconomic status in Vietnam veterans. J Trauma Stress 1995, 8:111-124.
53. McCarren M., Janes G.R., Goldberg J., Eisen S.A., True W.R., Henderson W.G. A twin study of the association of post-traumatic stress disorder and combat exposure with long-term socioeconomic status in Vietnam veterans. J Trauma Stress 1995, 8:111-124.
54. McEwen B.S., Seeman T. Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci 1999, 896:30-47.
55. Mosnaim A.D., Wolf M.E., Maturana P., Mosnaim G., Puente J., Kucuk O., Gilman-Sachs A. In vitro studies of natural killer cell activity in post traumatic stress disorder patients. Response to methionine-enkephalin challenge. Immunopharmacology 1993, 25:107-116.
56. Munker R., Marini F., Jiang S., Savary C., Owen-Schaub L., Andreeff M. Expression of CD95 (FAS) by gene transfer does not sensitize K562 to Fas-killing. Hematol Cell Ther 1997, 39:75-78.
57. Newport D.J., Heim C., Bonsall R., Miller A.H., Nemeroff C.B. Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 2004, 55:10-20.
58. Olff M., Langeland W., Gersons B.P. The psychobiology of PTSD: coping with trauma. Psychoneuroendocrinology 2005, 30:974-982.
59. Pervanidou P., Kolaitis G., Charitaki S., Margeli A., Ferentinos S., Bakoula C., et al. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology 2007, 32:991-999.
60. Pike J.L., Smith T.L., Hauger R.L., Nicassio P.M., Patterson T.L., McClintick J., Costlow C., Irwin M.R. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med 1997, 59:447-457.
61. Prigerson H.G., Maciejewski P.K., Rosenheck R.A. Combat trauma: trauma with highest risk of delayed onset and unresolved posttraumatic stress disorder symptoms, unemployment, and abuse among men. J Nerv Ment Dis 2001, 189:99-108.
62. Proroković A., Čavka M., Čubela Adorić V. Psychosomatic and depressive symptoms in civilians, refugees, and soldiers: 1993-2004 longitudinal study in Croatia. Croat Med J 2005, 46:275-281.
63. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-Inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol Psychiatry 2004, 55:745-751.
64. Segerstrom S.C., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30years of inquiry. Psychol Bull 2004, 130:601-630.
65. Schedlowski M., Jacobs R., Stratmann G., Richter S., Hädicke A., Tewes U., et al. Changes of natural killer cells during acute psychological stress. J Clin Immunol 1993, 13:119-126.
66. Schedlowski M., Hosch W., Oberbeck R., Benschop R.J., Jacobs R., Raab H.R., et al. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J Immunol (Baltimore, Md: 1950) 1996, 156:93-99.
67. Schnurr P.P., Green B.L. Trauma and health: physical health consequences of exposure to extreme stress 2004, American Psychological Association, Washington, DC.
68. Schnurr P.P., Jankowski M.K. Physical health and post-traumatic stress disorder: review and synthesis. Semin Clin Neuropsychiatry 1999, 4:295-304.
69. Solomon G.F., Segerstrom S.C., Grohr P., Kemeny M., Fahey J. Shaking up immunity: psychological and immunologic changes after a natural disaster. Psychosom Med 1997, 59:114-127.
70. Southwick S.M., Paige S., Morgan C.A., Bremner J.D., Krystal J.H., Charney D.S. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry 1999, 4:242-248.
71. Spielberger C.D., Gorsuch R.L., Lushene R.E. Manual for the State-Trait Anxiety Inventory 1970, Consulting Psychologists Press, Palo Alto.
72. Spivak B., Shohat B., Mester R., Avraham S., Gil-Ad I., Bleich A., Valevski A., Weizman A. Elevated levels of serum interleukin-1 beta in combat-related posttraumatic stress disorder. Biol Psychiatry 1997, 42:345-348.
73. Stein M.B., Yehuda R., Koverola C., Hanna C. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry 1997, 42:680-686.
74. Stam R. PTSD and stress sensitisation: a tale of brain and body Part 1: human studies. Neurosci Biobehav Rev 2007, 31:530-557.
75. Škarpa I., Rubeša G., Moro L., Manestar D., Petrovečki M., Rukavina D. Changes of cytolytic cells and perforin expression in patients with posttraumatic stress disorder. Croat Med J 2001, 42:551-555.
76. Tucker P., Ruwe W.D., Masters B., Parker D.E., Hossain A., Trautman R.P., et al. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry 2004, 56:121-128.
77. Vidović A., Vilibić M., Sabioncello A., Gotovac K., Rabatić S., Folnegović-Šmalc V., Dekaris D. Circulating lymphocyte subsets, natural killer cell cytotoxicity, and components of hypothalamic-pituitary-adrenal axis in Croatian war veterans with posttraumatic stress disorder-a cross-sectional study. Croat Med J 2007, 48:127-135.
78. von Kanel R., Hepp U., Kraemer B., Traber R., Keel M., Mica L., et al. Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J Psychiatr Res 2007, 41:744-752.
79. Voskoboinik I., Trapani J.A. Addressing the mysteries of perforin function. Immunol Cell Biol 2006, 84:66-71.
80. Vukušić H., Wilson J.P., Gregurek R., Komar Z., Pavić L., Gogić B. Secondary victimization of war veterans with post-traumatic stress disorder: the Croatian experience. Psychiatr Danub 2003, 15:13-24.
81. Vukšić-Mihaljević Ž., Mandić N., Laufer D., Barkić J., Filaković P. Combat-related posttraumatic stress disorder and social functioning. Eur J Psychiatry 1998, 12:225-231.
82. Zhou J., Olsen S., Moldovan J., Fu X., Sarkar F.H., Moudgil V.K., Callewaert D.M. Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol 1997, 178:108-116.
83. Watson-Burges I.P., Muller H.K., Jones I.H., Bradley A.J. Cell-mediated immunity in combat veterans with post-traumatic stress disorder. Med J Aust 1993, 159:513-516.
84. Weiss D.S., Marmar C.R. The impact of event scale-revised. Assessing psychological trauma and PTSD 1997, 399-411. The Guilford Press, New York. J.P. Wilson, T.M. Keane (Eds.).
85. Wessa M., Rohleder N. Endocrine and inflammatory alterations in post-traumatic stress disorder. Expert Rev Endocrinol Metab 2007, 2:91-122.
86. Wilson S.N., van der Kolk B., Burbridge J., Fisler R., Kradin R. Phenotype of blood lymphocytes in PTSD suggests chronic immune activation. Psychosomatics 1999, 40:222-225.
87. ICD-10, International statistical classification of diseases and health related problems, 10th revision 1992, World Health Organisation, World Health Organisation, Geneva. 1st ed.
88. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995, 52:583-593.
89. Yehuda R., Halligan S.L., Grossman R., Golier J.A., Wong C. The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and Holocaust survivors with and without posttraumatic stress disorder. Biol Psychiatry 2002, 52:393-403.